The Goldman Sachs Group, Inc. 13D and 13G filings for BioLife Solutions, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-01 4:19 pm Sale | 2024-09-30 | 13G | BioLife Solutions, Inc. BLFS | GOLDMAN SACHS GROUP INC GS | 161,488 0.400% | -2,314,754 (-93.48%) | Filing |
| 2024-02-02 10:11 am Purchase | 2023-12-29 | 13G | BioLife Solutions, Inc. BLFS | GOLDMAN SACHS GROUP INC GS | 2,476,242 5.500% | 2,476,242 (New Position) | Filing |